Twist Bioscience Corporation (TWST)

NASDAQ: TWST · Real-Time Price · USD

101.06

+9.51 (10.39%)

At close: Aug 3, 2026, 4:00 PM EDT

101.00

-0.06 (-0.06%)

After-hours: Aug 3, 2026, 7:43 PM EDT

Twist Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Net Income	-136.72	-77.67	-208.73	-204.62	-217.86	-152.1
Depreciation & Amortization	25.39	24.85	31.43	29.31	16.51	9.75
Stock-Based Compensation	66.47	64.46	50.93	30.28	79.66	37
Other Adjustments	-0.43	-46.66	46.86	3.57	2.66	2.49
Change in Receivables	-15.71	-22.38	8.44	-4.32	-9.62	-2.2
Changes in Inventories	-9.22	-4.23	7.99	7.24	-7.54	-19.49
Changes in Accounts Payable	4.3	9.33	-11.81	-2.51	7.38	8.54
Changes in Accrued Expenses	5.89	3.35	12.29	1.48	7.12	10.51
Changes in Other Operating Activities	-22.12	1.33	-1.5	-2.9	-2.7	-6.74
Operating Cash Flow	-53.07	-47.63	-64.09	-142.47	-124.39	-112.24
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Capital Expenditures	-40.05	-28	-5.08	-27.78	-101.86	-27.06
Purchases of Investments	-59.6	-49.39	-51.91	-76.35	-217.64	-58.8
Proceeds from Sale of Investments	59.51	50.14	53.91	154.74	100.48	242.49
Cash Acquisitions	-	-	-	-	-8.16	-0.48
Proceeds from Business Divestments	-	2.5	-	-	-5.76	-
Investing Cash Flow	-45.24	-24.76	-3.07	50.61	-232.93	156.16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Long-Term Debt Repaid	-	-	-	-	-1.56	-3.33
Net Long-Term Debt Issued (Repaid)	-	-	-	-	-1.56	-3.33
Issuance of Common Stock	13.82	13.56	10.87	5.32	279.85	343.36
Repurchase of Common Stock	-0.02	-0.02	-3.98	-4.41	-7.75	-10.85
Net Common Stock Issued (Repurchased)	13.8	13.54	6.89	0.91	272.09	332.52
Other Financing Activities	-	15	-	-	-	-
Financing Cash Flow	13.8	28.54	6.89	0.91	270.53	329.18

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Foreign Exchange Rate Adjustments	0.18	0.14	0.13	-0.03	-0.32	0.02
Net Cash Flow	-84.34	-43.71	-60.15	-90.98	-87.1	373.11

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Free Cash Flow	-93.12	-75.63	-69.17	-170.25	-226.24	-139.31
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-21.57%	-20.08%	-22.10%	-69.46%	-111.14%	-105.27%
Free Cash Flow Per Share	-1.52	-1.26	-1.19	-2.99	-4.20	-2.89
Levered Free Cash Flow	-172.54	-71.05	-175.4	-199.78	-300.5	-179.92
Unlevered Free Cash Flow	-181.72	-130.91	-188.1	-213.55	-305.15	-175.3

SEC Filings: 10-K · 10-Q